Billionaire doctor Patrick Soon-Shiong to take over 6 California hospitals

NantWorks, the company run by billionaire Patrick Soon-Shiong, MD, will take over operations at six California hospitals after acquiring controlling interest in Integrity Healthcare, the management company of Verity Health System.

The hospitals now under NantWorks control include St. Vincent Medical Center in Los Angeles, the city’s oldest hospital, as well as St. Francis Medical Center in Lynwood, O’Connor Hospital in San Jose, St. Louise Regional Hospital in Gilroy, Seton Medical Center in Daly City and Seton Coastside in Moss Beach. Combined, the facilities include 1,650 inpatient beds.

“Our commitment is to enhance the scope and resources of Verity Health so that, together, we can deliver the breakthrough treatments and cures that save lives, provide better patient outcomes and improve well-being,” Soon-Shiong said in a statement. “We will achieve this by applying the limitless powers of collaborative science and technology to transform healthcare practices and create a more efficient, more effective health system. Medical care is local and we strongly believe that community health systems should be supported with investment, technology and science to build next generation clinically integrated networks to drive better outcomes at a lower cost.”

He told the Los Angeles Times the acquisition provides the opportunity for experimenting “at scale” with some of his ideas, like geonomic testing. Those initiatives haven’t been widely adopted, with NantWorks reporting just 365 orders for those tests in the first quarter of 2017.

“It makes sense to me that this would be a way to guarantee faster adoption of some of the products of some of his companies,” Gerald Kominski, director of the UCLA Center for Health Policy Research, told the Times. “The ability of a hospital administrator to dictate clinical practice is limited, but that doesn’t mean there’s no influence.”

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.